Literature DB >> 3436361

Central mechanisms for apomorphine-induced emesis in the dog.

R K Harding1, H Hugenholtz, J Kucharczyk, J Lemoine.   

Abstract

In order to investigate whether different receptor populations mediate emesis induced by intracerebroventricular (i.c.v.) and intravenous (i.v.) apomorphine, adult beagle dogs were tested with various doses of the drug with and without central and peripheral pretreatment with the dopamine antagonist sulpiride. The threshold dose of apomorphine to induce emesis by i.c.v. injections was 30-50 times lower than via the i.v. route, while the response latencies after i.c.v. administration were typically longer and the number of bouts of vomiting greater. I.v. pretreatment with sulpiride was more effective than i.c.v. pretreatment in blocking emesis induced by i.v. apomorphine, whereas both i.v. and i.c.v. sulpiride effectively blocked vomiting after i.c.v. apomorphine. Finally, in separate experiments, surgical interruption of blood flow in the region of the area postrema permanently abolished the emetic response to i.c.v. apomorphine, but only transiently disrupted emesis induced by i.v. apomorphine. These data suggest the possibility that i.v. and i.c.v. apomorphine-induced emesis may be mediated by separate dopamine receptors on the cerebrospinal fluid-side and blood-side of the area postrema.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436361     DOI: 10.1016/0014-2999(87)90009-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.

Authors:  T Yoshikawa; N Yoshida; M Oka
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Mechanism of the prostanoid TP receptor agonist U46619 for inducing emesis in the ferret.

Authors:  Kelvin K W Kan; Man P Ngan; Man K Wai; John A Rudd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-11       Impact factor: 3.000

3.  Chemotherapy-induced kaolin intake is increased by lesion of the lateral parabrachial nucleus of the rat.

Authors:  Charles C Horn; Bart C De Jonghe; Kathleen Matyas; Ralph Norgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-26       Impact factor: 3.619

Review 4.  Opportunities for the replacement of animals in the study of nausea and vomiting.

Authors:  A M Holmes; J A Rudd; F D Tattersall; Q Aziz; P L R Andrews
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 5.  Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease.

Authors:  Nrupa Borkar; Huiling Mu; René Holm
Journal:  Asian J Pharm Sci       Date:  2017-12-06       Impact factor: 6.598

6.  Why can't rodents vomit? A comparative behavioral, anatomical, and physiological study.

Authors:  Charles C Horn; Bruce A Kimball; Hong Wang; James Kaus; Samuel Dienel; Allysa Nagy; Gordon R Gathright; Bill J Yates; Paul L R Andrews
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

7.  Antipsychotic-like activity of noni (Morinda citrifolia Linn.) in mice.

Authors:  Vijayapandi Pandy; Megala Narasingam; Zahurin Mohamed
Journal:  BMC Complement Altern Med       Date:  2012-10-19       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.